Your browser doesn't support javascript.
loading
Corrigendum: Antimicrobial resistance in the COVID-19 landscape: is there an opportunity for anti-infective antibodies and antimicrobial peptides?
Pérez de la Lastra, José M; Anand, Uttpal; González-Acosta, Sergio; López, Manuel R; Dey, Abhijit; Bontempi, Elza; delaNuez, Antonio Morales.
Afiliação
  • Pérez de la Lastra JM; Biotechnology of Macromolecules, Instituto de Productos Naturales y Agrobiología, IPNA (CSIC), San Cristóbal de la Laguna, Spain.
  • Anand U; CytoGene Research & Development LLP, Barabanki, Uttar Pradesh, India.
  • González-Acosta S; Biotechnology of Macromolecules, Instituto de Productos Naturales y Agrobiología, IPNA (CSIC), San Cristóbal de la Laguna, Spain.
  • López MR; Biotechnology of Macromolecules, Instituto de Productos Naturales y Agrobiología, IPNA (CSIC), San Cristóbal de la Laguna, Spain.
  • Dey A; Department of Life Sciences, Presidency University, Kolkata, India.
  • Bontempi E; National Interuniversity Consortium of Materials Science and Technology (INSTM) and Chemistry for Technologies Laboratory, Department of Mechanical and Industrial Engineering, University of Brescia, Brescia, Italy.
  • delaNuez AM; Biotechnology of Macromolecules, Instituto de Productos Naturales y Agrobiología, IPNA (CSIC), San Cristóbal de la Laguna, Spain.
Front Immunol ; 15: 1365827, 2024.
Article em En | MEDLINE | ID: mdl-38343533

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article